Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.53 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.46 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.46 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.46 |
| ▸ | DPP7 | Q9UHL4 | 8/20 | 0.43 |
| ▸ | DPP8 | Q6V1X1 | 4/20 | 0.43 |
| ▸ | DPP9 | Q86TI2 | 4/20 | 0.43 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.38 |
| ▸ | DPP4 | P27487 | 2/20 | 0.38 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.38 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.38 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21103612 | 1.00 | GSR (0.53) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL18868852 | 1.00 | GSR (0.53) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL24449947 | 0.98 | GSR (0.52) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL24063593 | 0.94 | GSR (0.45) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL18868716 | 0.94 | GSR (0.45) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL18868726 | 0.87 | GSR (0.52) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL19891853 | 0.87 | GSR (0.52) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL18819968 | 0.86 | GABRR1 (0.46) | GSRDPP7DPP8DPP9GABRR1 | |
| SCHEMBL20388742 | 0.86 | GABRR1 (0.46) | GSRDPP7DPP8DPP9GABRR1 | |
| SCHEMBL19891917 | 0.85 | GNAI3 (0.51) | GSRGNAI3GNAO1GNAI1DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180127518-A1 | CHITOSAN-DERIVATIVE COMPOUNDS AND METHODS OF CONTROLLING MICROBIAL POPULATIONS | UNITED STATES GOVERNMENT | 2018-05-10 | — | — | US | disclosed |
| EP-2294930-A2 | Expression of human milk proteins in transgenic plants | Ventria Bioscience (US) | 2011-03-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180127518-A1 | CHITOSAN-DERIVATIVE COMPOUNDS AND METHODS OF CONTROLLING MICROBIAL POPULATIONS | ARG1, NRDC, CHIA | GSR 1727/4885GNAI3 2109/4885GNAO1 2306/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.